Overview
Daniel Karp is a Hematologist in Houston, Texas. Dr. Karp is rated as an Experienced provider by MediFind in the treatment of Glomus Tympanum Tumor. His top areas of expertise are Adult Soft Tissue Sarcoma, Lung Cancer, Alveolar Soft Part Sarcoma, and Hodgkin Lymphoma.
His clinical research consists of co-authoring 112 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1515 Holcombe Blvd, Houston, TX 77030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
MD Anderson
Vince Cataldo is a Hematologist Oncology specialist and a Hematologist in Houston, Texas. Dr. Cataldo is rated as an Advanced provider by MediFind in the treatment of Glomus Tympanum Tumor. His top areas of expertise are Angiosarcoma, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Cataldo is currently accepting new patients.
Kelsey-Seybold Medical Group, PLLC
Bachar Samra is a Hematologist and an Oncologist in Spring, Texas. Dr. Samra is rated as an Advanced provider by MediFind in the treatment of Glomus Tympanum Tumor. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Acute Myeloid Leukemia (AML), and Acute Mountain Sickness.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Soft Tissue SarcomaDr. Karp isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Alveolar Soft Part SarcomaDr. Karp isDistinguished. Learn about Alveolar Soft Part Sarcoma.
- Bone TumorDr. Karp isDistinguished. Learn about Bone Tumor.
- Hodgkin LymphomaDr. Karp isDistinguished. Learn about Hodgkin Lymphoma.
- Lung CancerDr. Karp isDistinguished. Learn about Lung Cancer.
- Metastatic Pleural TumorDr. Karp isDistinguished. Learn about Metastatic Pleural Tumor.
- Advanced
- Anaplastic Thyroid CancerDr. Karp isAdvanced. Learn about Anaplastic Thyroid Cancer.
- AngiosarcomaDr. Karp isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Karp isAdvanced. Learn about Breast Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)
- Classical Hodgkin LymphomaDr. Karp isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Desmoplastic Small Round Cell Tumor
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Karp isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adrenal CancerDr. Karp isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Karp isExperienced. Learn about Adrenocortical Carcinoma.
- AgranulocytosisDr. Karp isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer